• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
US State Cannabis Policy Bundles Dataset.美国州大麻政策捆绑数据集。
Sci Data. 2025 Jun 10;12(1):971. doi: 10.1038/s41597-025-05284-2.
2
Getting "The whole picture": A review of international research on the outcomes of regulated cannabis supply.全面了解:关于合法大麻供应结果的国际研究综述
Int J Drug Policy. 2025 Aug;142:104796. doi: 10.1016/j.drugpo.2025.104796. Epub 2025 May 19.
3
Psychosocial interventions for cannabis use disorder.针对大麻使用障碍的心理社会干预措施。
Cochrane Database Syst Rev. 2016 May 5;2016(5):CD005336. doi: 10.1002/14651858.CD005336.pub4.
4
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
5
Pharmaceutical policies: effects of regulating drug insurance schemes.药品政策:规范药品保险计划的影响
Cochrane Database Syst Rev. 2022 May 3;5(5):CD011703. doi: 10.1002/14651858.CD011703.pub2.
6
The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review.戈谢病酶替代疗法的临床疗效和成本效益:一项系统评价。
Health Technol Assess. 2006 Jul;10(24):iii-iv, ix-136. doi: 10.3310/hta10240.
7
Education support services for improving school engagement and academic performance of children and adolescents with a chronic health condition.改善患有慢性病的儿童和青少年的学校参与度和学业成绩的教育支持服务。
Cochrane Database Syst Rev. 2023 Feb 8;2(2):CD011538. doi: 10.1002/14651858.CD011538.pub2.
8
Pharmacological treatments in panic disorder in adults: a network meta-analysis.成人惊恐障碍的药物治疗:网络荟萃分析。
Cochrane Database Syst Rev. 2023 Nov 28;11(11):CD012729. doi: 10.1002/14651858.CD012729.pub3.
9
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
10
Interventions for interpersonal communication about end of life care between health practitioners and affected people.干预健康从业者与受影响者之间关于临终关怀的人际沟通。
Cochrane Database Syst Rev. 2022 Jul 8;7(7):CD013116. doi: 10.1002/14651858.CD013116.pub2.

本文引用的文献

1
Adding Nuance to Understanding the Effects of Cannabis Legalization by Using Policy Bundles: A Study of Youth Mental Health.运用政策组合细化对大麻合法化影响的理解:一项关于青少年心理健康的研究
Subst Use Misuse. 2025;60(6):915-925. doi: 10.1080/10826084.2025.2466208. Epub 2025 Feb 16.
2
Cannabis policy bundles and traffic fatalities in the American States over time.随着时间的推移,美国各州的大麻政策组合与交通死亡人数。
Addiction. 2024 Nov;119(11):1998-2005. doi: 10.1111/add.16638. Epub 2024 Aug 6.
3
The highs and the lows: Recreational marijuana laws and mental health treatment.高低起伏:娱乐大麻法律和心理健康治疗。
Health Econ. 2023 Oct;32(10):2173-2191. doi: 10.1002/hec.4726. Epub 2023 Jun 30.
4
Marijuana Policy Bundles in the American States Over Time and Their Impact on the Use of Marijuana and Other Drugs.美国各州的大麻政策包随时间的变化及其对大麻和其他药物使用的影响。
Eval Rev. 2022 Apr;46(2):165-199. doi: 10.1177/0193841X221077795. Epub 2022 Feb 23.
5
Cannabis Legalization and College Mental Health.大麻合法化与大学生心理健康。
Curr Psychiatry Rep. 2021 Mar 3;23(4):17. doi: 10.1007/s11920-021-01231-1.
6
Do medical marijuana laws reduce addictions and deaths related to pain killers?医用大麻合法化是否能减少与止痛药相关的成瘾和死亡?
J Health Econ. 2018 Mar;58:29-42. doi: 10.1016/j.jhealeco.2017.12.007. Epub 2018 Feb 3.
7
Mapping medical marijuana: state laws regulating patients, product safety, supply chains and dispensaries, 2017.2017 年,医用大麻的定位:监管患者、产品安全、供应链和药房的州法律。
Addiction. 2017 Dec;112(12):2206-2216. doi: 10.1111/add.13910. Epub 2017 Jul 21.
8
Community-level policy responses to state marijuana legalization in Washington State.华盛顿州针对该州大麻合法化的社区层面政策应对措施。
Int J Drug Policy. 2017 Apr;42:102-108. doi: 10.1016/j.drugpo.2017.02.010. Epub 2017 Mar 30.
9
Words Can Be Deceiving: A Review of Variation Among Legally Effective Medical Marijuana Laws in the United States.言语可能具有欺骗性:对美国合法医用大麻法律差异的综述
J Drug Policy Anal. 2014 Dec;7(1):1-19. doi: 10.1515/jdpa-2014-0001.
10
Assessing the effects of medical marijuana laws on marijuana use: the devil is in the details.评估医用大麻法律对大麻使用的影响:细节决定成败。
J Policy Anal Manage. 2015 Winter;34(1):7-31. doi: 10.1002/pam.21804.

美国州大麻政策捆绑数据集。

US State Cannabis Policy Bundles Dataset.

作者信息

Richardson Lilliard E, Mallinson Daniel J, Altaf Shazib, Neeley Grant

机构信息

School of Public Policy, Penn State, 509 Welch Building, University Park, PA, 16802, USA.

School of Public Affairs, Penn State Harrisburg, 777 W. Harrisburg Pike, Middletown, PA, 17057, USA.

出版信息

Sci Data. 2025 Jun 10;12(1):971. doi: 10.1038/s41597-025-05284-2.

DOI:10.1038/s41597-025-05284-2
PMID:40494846
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12152162/
Abstract

Cannabis policies across the U.S. states vary considerably, and we categorize state data into three policy bundles: pharmaceutical, permissive, and fiscal. Each of the bundles is comprised of twelve constituent policies that reflect the dimensions of state cannabis policy. Factor analysis confirmed the three policy dimensions, and the bundles for each state in each year were transformed to range from 0 to 100. This results in two datasets - one with the original 36 dichotomous policy indicators and one with the three policy bundles for each state from 1994 to 2023. The bundles provide researchers with data to understand the effects of cannabis legalization on myriad policy outcomes (e.g., public health or crime). The bundles capture significant variation in policy design cross-sectionally between the states and within the states over time. This provides an advancement over studies that treat legalization as a dichotomy, thus ignoring variation in policy design that is inherently related to impacts of interest, such as health, crime, and social outcomes.

摘要

美国各州的大麻政策差异很大,我们将州数据分为三类政策组合:制药类、宽松类和财政类。每个组合由十二项构成政策组成,这些政策反映了州大麻政策的各个方面。因子分析证实了这三个政策维度,并且每年每个州的政策组合都被转换为0到100的范围。这产生了两个数据集——一个包含原始的36个二分法政策指标,另一个包含1994年至2023年每个州的三个政策组合。这些政策组合为研究人员提供数据,以了解大麻合法化对众多政策结果(如公共卫生或犯罪)的影响。这些政策组合在各州之间以及各州内部随时间的推移,捕捉到了政策设计方面的显著差异。这比那些将合法化视为二分法的研究有了进步,从而忽略了与健康、犯罪和社会结果等相关影响内在相关的政策设计差异。